NY suddenly started withholding names of medical facilities with cases of deadly drug-resistant fungus Candida auris. We got ...
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...
Biosciences' lead drug candidate, VE303, has been reported to demonstrate efficacy in preventing recurrent Clostridioides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback